1. Australia Stocks

  2. •

    Industrials

  3. •

    Consulting Services
ALS Limited

ALS Limited

CPBLF
ALS LimitedUS flagOther OTC
16.11
USD
- -
- -
8.18BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
3.95
3.74
3.33
2.98
2.52
2.89
3.42
3.79
3.65
4.37
4.71
5.08
6.19
Basic EPS, GAAP
0.62
0.38
-0.41
-0.53
0.16
0.1
0.32
0.26
0.36
0.39
0.6
0.03
0.53
Free Cash Flow per Basic Share
0.36
0.38
0.32
0.21
0.23
-0.15
-0.22
-0.25
-0.17
-0.25
-0.3
-0.31
-0.34
Dividend per Share
0.28
0.25
0.18
0.16
0.12
0.16
0.2
0.23
0.15
0.27
0.37
0.39
0.37
Book Value per Share
2.94
3.63
2.9
2.68
2.49
2.23
2.31
2.28
2.49
2.58
2.84
2.47
2.64
Tangible Book Value per Share
0.52
0.02
-0.05
0.45
0.4
0.28
0.12
-0.1
-0.12
-0.42
-0.07
-0.65
-0.81
Basic Weighted Avg Shares
368
402
427
458
504
501
487
483
482
482
484
484
484
Sales/Revenue/Turnover
1,456
1,503
1,422
1,365
1,272
1,447
1,665
1,832
1,761
2,108
2,279
2,462
2,999
Operating Margin (%)
23.56
15.81
13.84
10.7
13.29
14.32
15.46
15.13
15.12
15.1
18.95
16.32
14.15
Depreciation Expense
55
83
96
102
68
71
75
133
133
139
152
174
234
Net Income, GAAP
227
154
-174
-241
82
52
154
128
173
190
291
13
256
Effective Tax Rate (%)
28.47
27.4
- -
- -
29.4
41.59
27.1
48.38
29.94
31.94
29.28
87.63
28.62
Profit Margin (%)
15.62
10.27
-12.27
-17.63
6.41
3.58
9.24
6.98
9.8
9.03
12.78
0.52
8.54
Working Capital
305
252
397
500
473
386
64
350
233
-639
140
176
392
LT Debt
522
750
935
748
701
696
514
1,569
927
1,269
1,269
1,554
1,929
Total Equity
997
1,419
1,228
1,128
1,185
1,122
1,103
1,111
1,080
994
1,378
1,197
1,294
Return on Invested Capital (%)
16.34
9
- -
- -
6.28
6.46
10.14
5.91
7.4
8.66
10.57
1.67
9.37
Return on Capital (%)
15.46
8.74
- -
- -
5.12
3.53
9.48
5.93
7.61
7.91
10.67
0.61
9.58
Return on Common Equity (%)
22.23
12.13
-12.92
-19.51
6.58
4.37
13.7
11.49
15.01
15.58
22.23
1
20.72

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.35%
4.59%
8.12%
Free Cash Flow
-6.36%
9.81%
8.77%
Net Income, GAAP
193.63%
377.75%
1,886.05%
Sales/Revenue/Turnover
8.18%
10.76%
21.85%
Total Cash Common Dividend
13.1%
16.62%
-6.59%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2,279
2024
- -
- -
- -
- -
2,462
2025
- -
- -
- -
- -
2,999

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.6
2024
- -
- -
- -
- -
0.03
2025
- -
- -
- -
- -
0.53

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.37
2024
- -
- -
- -
- -
0.39
2025
- -
- -
- -
- -
0.37

Company Description

APIChat
CEO
Malcolm Deane
Full Time Employees
19,565
Sector
Industrials
Industry
Consulting Services
Address
299 Coronation Drive Milton QLD Australia 4064
IPO Date
Sep 4, 2012
Website
alsglobal.com
Similar Companies
Enento Group Oyj (ENENTO.HE)
ALBERT Inc. (3906.T)
Franklin Covey Co. (FC)
Karbon-X Corp. (KARX)
Bluebik Group Public Company Limited (BBIK.BK)
Tam Development Co. (9570.SR)
Business
ALS Limited provides testing, inspection, certification, and verification services across more than 370 sites in over 65 countries worldwide. Headquartered in Brisbane, Australia, and founded in 1863 as Campbell Brothers, the company renamed to ALS Limited in 2012 after divesting its legacy manufacturing operations to focus on laboratory and technical services. It operates through three primary divisions: Commodities, offering geochemistry, metallurgy, coal, mine site services, and inspection for the global mining industry throughout the resource life-cycle from exploration to rehabilitation; Life Sciences, providing environmental monitoring, food and pharmaceutical testing including stability studies, animal health, electronics, consumer products, and cannabis analytical services; and Industrial, delivering diagnostic testing, asset care, tribology, and engineering services for energy, resources, transportation, infrastructure, and transformer fluid monitoring sectors. ALS employs over 20,000 staff and serves clients in mining, pharmaceuticals, environmental consulting, food production, and regulated industries across Australia, Asia Pacific, North America, South America, Europe, Africa, and the Middle East. In 2025, ALS reported solid FY25 results with revenue reaching $3 billion, driven by Life Sciences growth offsetting softer Commodities activity, and launched a fully underwritten $350 million equity raising including a $40 million share purchase plan to fund a $230 million brownfield expansion of key hub laboratories in Lima, Sydney, Bangkok, and Prague, alongside $120 million for M&A and growth initiatives; recent acquisitions include US-based York Analytical Laboratories, Germany's Wessling Holding GmbH & Co., and Nuvisan in April 2024 to enhance drug discovery and clinical services, with integration on track ahead of schedule.

Company News

APIChat

  • seekingalpha.com

    ALS Limited (CPBLF) Q4 2026 Earnings Call Transcript

  • defenseworld.net

    ALS (OTCMKTS:CPBLF) & Ipsos (OTCMKTS:IPSOF) Financial Survey

  • proactiveinvestors.com

    ALS Ltd delivers $3 billion revenue in FY25, unveils $350 million equity raise